Elsevier

Mayo Clinic Proceedings

Volume 85, Issue 10, October 2010, Pages 949-954
Mayo Clinic Proceedings

CONCISE REVIEW FOR CLINICIANS
Ethical Decision Making With End-of-Life Care: Palliative Sedation and Withholding or Withdrawing Life-Sustaining Treatments

https://doi.org/10.4065/mcp.2010.0201Get rights and content

Palliative sedation (PS) is the use of medications to induce decreased or absent awareness in order to relieve otherwise intractable suffering at the end of life. Although uncommon, some patients undergoing aggressive symptom control measures still have severe suffering from underlying disease or therapy-related adverse effects. In these circumstances, use of PS is considered. Although the goal is to provide relief in an ethically acceptable way to the patient, family, and health care team, health care professionals often voice concerns whether such treatment is necessary or whether such treatment equates to physician-assisted suicide or euthanasia. In this review, we frame clinical scenarios in which PS may be considered, summarize the ethical underpinnings of the practice, and further differentiate PS from other forms of end-of-life care, including withholding and/or withdrawing life-sustaining therapy and physician-assisted suicide and euthanasia.

Section snippets

PRACTICAL ISSUES

The following sections explore issues of the application of PS. Detailed guidelines for practicing PS, although beyond the scope of this article, have been published.5

SUMMARY

Palliative sedation has an important place on the continuum of appropriate palliative care at the end of life. It is appropriate therapy for refractory and unacceptably severe suffering. As with any other therapy, the patient or surrogate should be informed of potential adverse effects, including loss of social interaction and potential for life-threatening aspiration or respiratory depression. Palliative medicine teams should be involved, if possible, in any case in which PS is considered.

Acknowledgments

We acknowledge W. David Mauck, MD, of the Department of Anesthesiology, Division of Pain Medicine, for his contribution to concepts in this article.

CME Questions About Palliative Sedation

  • 1.

    A 61-year-old woman with metastatic breast cancer is hospitalized for dyspnea. She has symptomatic pleural effusions with lung, brain, and bone metastases. The pleural effusions are drained, and morphine initiated at 6 mg per hour resolves her dyspnea and hypoxia. That night the patient clearly shows signs of imminent death and develops agitated terminal delirium, which does not respond to haloperidol and other supportive cares. Her family knows she will die soon and wants her to be

REFERENCES (36)

  • NI Cherny et al.

    Sedation in the management of refractory symptoms: guidelines for evaluation and treatment

    J Palliat Care

    (1994)
  • Vacco v. Quill, 521 U.S. 793 (1997). http://caselaw.lp.findlaw.com/scripts/getcase.pl?court=US&vol=521&invol=793....
  • Washington et al v. Glucksberg et al, 117 S.Ct. 2258, 138 L.Ed.2d 772 (1997)....
  • NI Cherny et al.

    European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care

    Palliat Med

    (2009)
  • RC Archibold

    Doctor is charged in death of Jackson

    New York Times

    (February 8, 2010)
  • D Grady

    Medical and ethical questions raised on deaths of critically ill patients

    New York Times

    (July 20, 2006)
  • A de Graeff et al.

    Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards

    J Palliat Med

    (2007)
  • WR Greene et al.

    Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer

    South Med J

    (1991)
  • Cited by (0)

    On completion of this article, you should be able to (1) define the practice of palliative sedation and describe in general terms how it is administered, (2) describe the appropriate clinical scenario in which palliative sedation may be considered, and (3) differentiate the ethical and legal permissibility of withholding and withdrawing life-sustaining treatments and accepted comfort measures (such as palliative sedation) from that of physician-assisted suicide and euthanasia.

    An earlier version of this article appeared Online First.

    1

    Dr Mueller is a member of the Boston Scientific Patient Safety Advisory Board and is an Associate Editor of Journal Watch General Medicine, but neither of these activities is related to the article.

    View full text